value was found to be 49.70 ± 1.10 µg/mL against A549 human lung cancer cells. These results suggested multiple incorporations in the biomedical field, with CuO NPs offering versatile properties that could be tailored for wider applications.
Chattaraj et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: